BioPharmX down 15% after hours on 1:25 reverse stock split

Apr. 15, 2019 4:39 PM ETBy: Douglas W. House, SA News Editor
  • Aimed at regaining compliance with NYSE American listing requirements, BioPharmX (BPMX) will execute a 1:25 reverse split of its common stock on April 25. Post-split trading will commence on April 26.
  • Shares are down 15% after hours.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.